Author:
Fagien Steven,McChesney Patricia,Subramanian Meenakshi,Jones Derek H.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,General Medicine,Surgery
Reference40 articles.
1. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study;Ascher;J Eur Acad Dermatol Venereol,2014
2. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study;Rzany;Br J Dermatol,2014
3. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction;Jones;Dermatol Surg,2016
4. Single-center, double-blind, randomized study to evaluate the efficacy of 4% lidocaine cream versus vehicle cream during botulinum toxin type A treatments;Carruthers;Dermatol Surg,2005
5. Efficacy of skin cooling and EMLA cream application for pain relief of periocular botulinum toxin injection;Elibol;Ophthal Plast Reconstr Surg,2007
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献